TXA for GI Bleeds? The HALT-IT Trial

July 15, 2020 00:26:28
TXA for GI Bleeds?  The HALT-IT Trial
Critical Care Perspectives in Emergency Medicine
TXA for GI Bleeds? The HALT-IT Trial

Jul 15 2020 | 00:26:28

/

Show Notes

The use of tranexamic acid (TXA) has markedly increased since the results of the CRASH-II trial were published.  In addition to its use in trauma, TXA has been evaluated and used in numerous other conditions, including post-partum hemorrhage and epistaxis.  Recently, the HALT-IT Trial was published online in the Lancet, which evaluated the use of TXA in patients with acute gastrointestinal bleeding.  In this podcast we discuss the HALT-IT Trial and its implications for clinical practice. 

You can get CME credit for this episode here!Click here for CME Account Creation Instructions

Other Episodes

Episode 0

April 13, 2023 00:28:58
Episode Cover

Should We Administer Steroids in Severe CAP?

In recent years,  numerous trials have investigated the administration of corticosteroids in patients with pneumonia and have produced mixed results.  In this podcast, we...

Listen

Episode 0

April 20, 2021 00:29:53
Episode Cover

The Physiologically Difficult Airway

Airway guru Dr. Ken Butler joins us for this podcast to discuss some great pearls and pitfalls in intubating patients with physiologic derangements that...

Listen

Episode 0

June 15, 2023 00:30:21
Episode Cover

Do Etomidate and Propofol Increase Mortality in the Critically Ill?

Both etomidate and propofol are commonly used sedative agents in critically ill patients.  Recent literature has suggested that these agents may result in increased...

Listen